Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03592316 · ClinicalTrials.gov registry record · NA

Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients

A NA study of Lower Extremity Amputation, sponsored by University of California, San Francisco.

Completed
Registry status
NA
Development phase
11
Enrollment target
1
Study location

NCT03592316 is a NA study of Lower Extremity Amputation that has completed, run by University of California, San Francisco. The registered enrollment target is 11 participants, below the 19-participant average among 3 other Lower Extremity Amputation trials with a reported enrollment target (42% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03592316, a NA study of Lower Extremity Amputation, has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
NA
Development phase
11 participants
Enrollment target
1
Study location

Study Summary

The LEAP protocol is a prospective cohort study of dysvascular patients designed to determine whether implementation of a multi-disciplinary lower extremity amputation protocol in the peri-operative period can shorten post-operative length of stay in patients undergoing trans-tibial or trans-femoral amputations. A consecutive sample of patients diagnosed with peripheral vascular disease and/or diabetes requiring major lower extremity amputation will be enrolled in the study and compared to retrospective controls.

Conditions Studied

Interventions

  • OTHER Lower Extremity Amputation Pathway

Study Locations (1)

California

  • Community Regional Medical Center - Fresno

Trial Details

FieldValue
Enrollment Target 11 participants
Start Date 2018-11-14
Est. Completion 2020-12-31
Phase NA

What the Registry Record Tells You About NCT03592316

The ClinicalTrials.gov registry entry for NCT03592316 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 19-participant average among 3 other Lower Extremity Amputation trials with a reported enrollment target (42% lower). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Lower Extremity Amputation appearing as the primary indexed condition, and to 1 intervention - of which Lower Extremity Amputation Pathway is the first listed.

NCT03592316 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT03592316 about?

NCT03592316 is a clinical study titled "Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients". The LEAP protocol is a prospective cohort study of dysvascular patients designed to determine whether implementation of a multi-disciplinary lower extremity amputation protocol in the peri-operative period can shorten post-operative length of stay in patients undergoing trans-tibial or trans-femoral...

What is the current status of trial NCT03592316?

This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2018-11-14. Estimated completion is 2020-12-31.

What conditions does trial NCT03592316 study?

This clinical trial studies the following conditions: Lower Extremity Amputation.

What interventions are being tested in trial NCT03592316?

The interventions under investigation include: Lower Extremity Amputation Pathway (OTHER).

Who is sponsoring clinical trial NCT03592316?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03592316 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lower Extremity Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.